ImmunityBio amends stock sale agreement to authorize $460M offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Form 424B5 ImmunityBio, Inc.
December 29, 2025 6:02 AM ESTTable of Contents
Filed Pursuant to Rule 424(b)(5)
File No. 333-278770
PROSPECTUS SUPPLEMENT
(To Prospectus dated April 17, 2024)
... More
Form 8-K ImmunityBio, Inc. For: Dec 23
December 29, 2025 6:02 AM ESTfalse 0001326110 0001326110 2025-12-23 2025-12-23... More
